Therapeutic Options for Difficult to Treat Bacteria and Candida auris

Pp: 219-262 (44)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

The therapy of multidrug-resistant Gram-positive, Gram-negative, and Candida auris is challenging and has emerged as a major threat to human health. Commonly used drugs have become increasingly resistant, which has led to an absence of reliable options and use of current agents in combination. While this has led to the development of newer drugs, most of them are not available in the United States or are yet to be approved by the FDA. Described here is a comprehensive overview of antimicrobial resistance and recent developments in therapy for methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp, extended-spectrum β- lactamases (ESBL's), carbapenemase-producing Enterobacteriaceae (CRE), multi-drug resistant Pseudomonas aeruginosa (PSA), multi-drug resistant Acinetobacter (ACB), and Candida auris.

Recommended Chapters

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books